Endo International | ENDP - الدائنين التجاريين



الدائنين التجاريين تغيير تاريخ
AbbVie USD 3.59B 28.65B 2025-12
Amarin USD 45.36M 8.64M 2025-12
ANI Pharmaceuticals USD 62.58M 7.21M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Coherus Biosciences USD 9.91M 14.98M 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
Merck USD 4.15B 102M 2025-09
Novartis USD 4.46B 99M 2025-12
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 5.02B 142M 2025-09
Phibro Animal Health USD 133.3M 2.7M 2025-12
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12
Zoetis USD 487M 77M 2025-12